Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > China Daily Article

<< Previous

Bullboard Posts

Next >>

Comment by davikingon Nov 06, 2024 10:45pm

63 Views

Post# 36300208

RE:RE:RE:RE:RE:RE:RE:RE:China Daily Article

Best to you and all of us!
It has taken so long and we seem so far away at 3 entrants/month that it's like a dream. There have been so many links/posts showing the different positive aspects that PMX provides, that I can't believe that Spectral isn't worth $2B but best dreams rarely come true, especially when you rely on others to get to the finish line.
As sad as it sounds, at this point, $2 a share is a dream I can live with. Everything else would be Dom Perignon!

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market